Literature DB >> 31990291

High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia.

Othman Al-Sawaf1,2, Esther Lilienweiss1,2, Jasmin Bahlo1,2, Sandra Robrecht1,2, Anna-Maria Fink1,2, Michaela Patz1,2, Maneesh Tandon3, Yanwen Jiang4, William Schary5, Matthias Ritgen6, Eugen Tausch7, Stephan Stilgenbauer7,8, Barbara Eichhorst1,2, Kirsten Fischer1,2, Michael Hallek1,9,10,11, Karl-Anton Kreuzer1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31990291     DOI: 10.1182/blood.2019003451

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  8 in total

1.  Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study.

Authors:  Othman Al-Sawaf; Can Zhang; Tong Lu; Michael Z Liao; Anesh Panchal; Sandra Robrecht; Travers Ching; Maneesh Tandon; Anna-Maria Fink; Eugen Tausch; Christof Schneider; Matthias Ritgen; Sebastian Böttcher; Karl-Anton Kreuzer; Brenda Chyla; Dale Miles; Clemens-Martin Wendtner; Barbara Eichhorst; Stephan Stilgenbauer; Yanwen Jiang; Michael Hallek; Kirsten Fischer
Journal:  J Clin Oncol       Date:  2021-10-28       Impact factor: 44.544

Review 2.  Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype.

Authors:  Thomas Chatzikonstantinou; Christos Demosthenous; Panagiotis Baliakas
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

3.  Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations.

Authors:  Panagiotis Baliakas; Blanca Espinet; Clemens Mellink; Marie Jarosova; Anastasia Athanasiadou; Paolo Ghia; Arnon P Kater; David Oscier; Claudia Haferlach; Kostas Stamatopoulos
Journal:  Hemasphere       Date:  2022-03-25

4.  TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.

Authors:  Silvia Ramos-Campoy; Anna Puiggros; Joanna Kamaso; Sílvia Beà; Sandrine Bougeon; María José Larráyoz; Dolors Costa; Helen Parker; Gian Matteo Rigolin; María Laura Blanco; Rosa Collado; Idoya Ancín; Rocío Salgado; Marco A Moro-García; Tycho Baumann; Eva Gimeno; Carol Moreno; Marta Salido; Xavier Calvo; María José Calasanz; Antonio Cuneo; Florence Nguyen-Khac; David Oscier; Claudia Haferlach; Jonathan C Strefford; Jacqueline Schoumans; Blanca Espinet
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

5.  Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).

Authors:  Anna Puiggros; Silvia Ramos-Campoy; Joanna Kamaso; Mireia de la Rosa; Marta Salido; Carme Melero; María Rodríguez-Rivera; Sandrine Bougeon; Rosa Collado; Eva Gimeno; Rocío García-Serra; Sara Alonso; Marco Antonio Moro-García; María Dolores García-Malo; Xavier Calvo; Leonor Arenillas; Ana Ferrer; Tuomo Mantere; Alexander Hoischen; Jacqueline Schoumans; Blanca Espinet
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

6.  Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.

Authors:  Arnon P Kater; Jenny Qun Wu; Thomas Kipps; Barbara Eichhorst; Peter Hillmen; James D'Rozario; Sarit Assouline; Carolyn Owen; Tadeusz Robak; Javier de la Serna; Ulrich Jaeger; Guillaume Cartron; Marco Montillo; Julie Dubois; Eric Eldering; Clemens Mellink; Anne-Marie Van Der Kevie-Kersemaekers; Su Young Kim; Brenda Chyla; Elizabeth Punnoose; Christopher R Bolen; Zoe June Assaf; Yanwen Jiang; Jue Wang; Marcus Lefebure; Michelle Boyer; Kathryn Humphrey; John F Seymour
Journal:  J Clin Oncol       Date:  2020-09-28       Impact factor: 44.544

7.  The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.

Authors:  Andrea Visentin; Laura Bonaldi; Gian Matteo Rigolin; Francesca Romana Mauro; Annalisa Martines; Federica Frezzato; Stefano Pravato; Leila Romano Gargarella; Maria Antonella Bardi; Maurizio Cavallari; Eleonora Volta; Francesco Cavazzini; Mauro Nanni; Monica Facco; Francesco Piazza; Anna Guarini; Robin Foà; Gianpietro Semenzato; Antonio Cuneo; Livio Trentin
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

8.  Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.

Authors:  Silvia Ramos-Campoy; Anna Puiggros; Sílvia Beà; Sandrine Bougeon; María José Larráyoz; Dolors Costa; Helen Parker; Gian Matteo Rigolin; Margarita Ortega; María Laura Blanco; Rosa Collado; Rocío Salgado; Tycho Baumann; Eva Gimeno; Carolina Moreno; Francesc Bosch; Xavier Calvo; María José Calasanz; Antonio Cuneo; Jonathan C Strefford; Florence Nguyen-Khac; David Oscier; Claudia Haferlach; Jacqueline Schoumans; Blanca Espinet
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.